O'Shaughnessy Asset Management, LLC Anavex Life Sciences Corp. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$9.74 - $17.69 $110,373 - $200,463	-11,332 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.88 - $23.31 $118,160 - $163,170	7,000 Added 161.59%	11,332 $196,000
Q3 2021 Nov 10, 2021	SELL	$16.82 - $25.75 $58,331 - $89,301	-3,468 Reduced 44.46%	4,332 $78,000
Q1 2021 May 14, 2021	BUY	$5.17 - $16.13 $40,320 - $125,797	7,799 Added 779900.0%	7,800 $117,000
Q4 2019 Feb 12, 2020	BUY	$2.31 - $3.14 $2 - $3	1 New	1 $0

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $704M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.